Review



aptamer-based 1.3k target proteomics platform  (SomaLogic)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    SomaLogic aptamer-based 1.3k target proteomics platform
    Aptamer Based 1.3k Target Proteomics Platform, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aptamer-based+1%2E3k+target+proteomics+platform/aptamer+based+proteomics+platform/pmc11250564-311-14-14
    Average 90 stars, based on 1 article reviews
    aptamer-based 1.3k target proteomics platform - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren’s disease
    Article Snippet: Using an existing, yet unpublished dataset, we estimated proteomic changes in the circulation using Somalogic aptamer-based 1.3K target proteomics platform (Figure 4A).

    Generated:

    Article Title: Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren’s disease
    Article Snippet: Using an existing, yet unpublished dataset, we estimated proteomic changes in the circulation using Somalogic aptamer-based 1.3K target proteomics platform (Figure 4A).

    Labeling:

    Article Title: Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren’s disease
    Article Snippet: Using an existing, yet unpublished dataset, we estimated proteomic changes in the circulation using Somalogic aptamer-based 1.3K target proteomics platform (Figure 4A).

    Functional Assay:

    Article Title: Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren’s disease
    Article Snippet: Using an existing, yet unpublished dataset, we estimated proteomic changes in the circulation using Somalogic aptamer-based 1.3K target proteomics platform (Figure 4A).

    RNA Sequencing Assay:

    Article Title: Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren’s disease
    Article Snippet: Using an existing, yet unpublished dataset, we estimated proteomic changes in the circulation using Somalogic aptamer-based 1.3K target proteomics platform (Figure 4A).



    Similar Products

    90
    SomaLogic aptamer-based 1.3k target proteomics platform
    Aptamer Based 1.3k Target Proteomics Platform, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aptamer-based+1%2E3k+target+proteomics+platform/aptamer+based+proteomics+platform/pmc11250564-311-14-14
    Average 90 stars, based on 1 article reviews
    aptamer-based 1.3k target proteomics platform - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results